These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Diagnosis of pancreatic carcinoma: role of FDG PET. Keogan MT; Tyler D; Clark L; Branch MS; McDermott VG; DeLong DM; Coleman RE AJR Am J Roentgenol; 1998 Dec; 171(6):1565-70. PubMed ID: 9843289 [TBL] [Abstract][Full Text] [Related]
5. Is positron emission tomography using 18F-fluorodeoxyglucose and 11C-acetate valuable in diagnosing indeterminate pancreatic masses? Rasmussen I; Sörensen J; Långström B; Haglund U Scand J Surg; 2004; 93(3):191-7. PubMed ID: 15544073 [TBL] [Abstract][Full Text] [Related]
6. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430 [TBL] [Abstract][Full Text] [Related]
7. [Comparative assessment of the diagnostic capacities of PET with 18FDG and 1-[11C] sodium butyrate in the examination of patients with tumors of the brain and cerebral circulatory disorders: results of semiquantitative assessment]. Kostenikov NA; Fadeev NP; Tiutin LA; Savello VE; Ryzhkova DV Vestn Rentgenol Radiol; 2002; (4):4-8. PubMed ID: 12577659 [TBL] [Abstract][Full Text] [Related]
8. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771 [TBL] [Abstract][Full Text] [Related]
9. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Bares R; Klever P; Hauptmann S; Hellwig D; Fass J; Cremerius U; Schumpelick V; Mittermayer C; Büll U Radiology; 1994 Jul; 192(1):79-86. PubMed ID: 8208970 [TBL] [Abstract][Full Text] [Related]
10. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094 [TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of benign and malign pancreatic masses with 18F-fluordeoxyglucose-positron emission tomography recorded with a dual-head coincidence gamma camera. Singer E; Gschwantler M; Plattner D; Kriwanek S; Armbruster C; Schueller J; Feichtinger H; Roka R; Moeschl P; Weiss W; Kroiss A Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):471-8. PubMed ID: 17489057 [TBL] [Abstract][Full Text] [Related]
12. [Can the extent of pancreatic tumors be evaluated reliably enough by positron emission tomography (PET)]. Sendler A; Avril N; Roder JD; Schwaiger M; Siewert JR Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1485-7. PubMed ID: 9931919 [TBL] [Abstract][Full Text] [Related]
15. [The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions]. Voth M; Opfermann T; Gottschild D Zentralbl Chir; 2003 May; 128(5):375-8. PubMed ID: 12813634 [TBL] [Abstract][Full Text] [Related]
16. [18 F-fluorodeoxyglucose positron emission tomography for characterization and initial staging of pancreatic tumors]. Valinas R; Barrier A; Montravers F; Houry S; Talbot JN; Huguier M Gastroenterol Clin Biol; 2002 Oct; 26(10):888-92. PubMed ID: 12434099 [TBL] [Abstract][Full Text] [Related]
17. [Role of 18F-FDG PET scan in the differential diagnosis of large pancreatic masses]. Tlostanova MS; Tiutin LA; Ryzhkova DV; Pavlovskiĭ AV; Popov SA Vopr Onkol; 2008; 54(4):439-44. PubMed ID: 18942397 [TBL] [Abstract][Full Text] [Related]
18. [The role of positron emission tomography with C18-Fluorodeoxyglucose in clinical oncology]. Granov AM; Tiushin LA; Tlostanova MS; Kostenikov NA; Ryzhkova DV; Savello VE; Stanzhevskiĭ AA Vopr Onkol; 2003; 49(5):563-73. PubMed ID: 14682126 [TBL] [Abstract][Full Text] [Related]
19. 18FDG-positron emission tomography in pancreatic cancer. Zimny M; Buell U Ann Oncol; 1999; 10 Suppl 4():28-32. PubMed ID: 10436780 [TBL] [Abstract][Full Text] [Related]
20. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]